1. Home
  2. GOAI vs CGTX Comparison

GOAI vs CGTX Comparison

Compare GOAI & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GOAI

Eva Live Inc. Common Stock

N/A

Current Price

$3.27

Market Cap

122.9M

Sector

Technology

ML Signal

N/A

Logo Cognition Therapeutics Inc.

CGTX

Cognition Therapeutics Inc.

HOLD

Current Price

$1.13

Market Cap

132.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOAI
CGTX
Founded
2015
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
122.9M
132.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
GOAI
CGTX
Price
$3.27
$1.13
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$3.33
AVG Volume (30 Days)
311.2K
984.9K
Earning Date
04-10-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.25
N/A
Revenue
$15,656,703.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$14.37
N/A
Revenue Growth
86.84
N/A
52 Week Low
$1.32
$0.22
52 Week High
$18.00
$3.83

Technical Indicators

Market Signals
Indicator
GOAI
CGTX
Relative Strength Index (RSI) N/A 33.41
Support Level N/A $1.08
Resistance Level N/A $1.49
Average True Range (ATR) 0.00 0.09
MACD 0.00 -0.03
Stochastic Oscillator 0.00 11.49

Price Performance

Historical Comparison
GOAI
CGTX

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: